Bacterial Vaginosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin. Treatment includes antibiotics.
The Bacterial Vaginosis -Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects.
Key Targets in the Bacterial Vaginosis pipeline drugs market
The key targets in the Bacterial Vaginosis pipeline drugs market are 23S Ribosomal RNA, Bacterial Cell Wall, DNA, Lanosterol 14 Alpha Demethylase, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2.
Bacterial Vaginosis Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Bacterial Vaginosis Pipeline Drugs Market
The key mechanisms of action in the Bacterial Vaginosis pipeline drugs market are 23S Ribosomal RNA inhibitor, Bacterial Cell Wall inhibitor, DNA inhibitor, Lanosterol 14 Alpha Demethylase inhibitor, Prostaglandin G/H Synthase 1 inhibitor, and Prostaglandin G/H Synthase 2 inhibitor.
Bacterial Vaginosis Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free report sample
Key Molecule Types in the Bacterial Vaginosis Pipeline Drugs Market
The key molecule types in the Bacterial Vaginosis pipeline drugs market are small molecule, biologic, peptide, and recombinant enzyme.
Bacterial Vaginosis Pipeline Drugs Market, by Molecule Types
To get more insights on key molecule types, download a free report sample
Key RoA in the Bacterial Vaginosis Pipeline Drugs Market
The key routes of administration in the Bacterial Vaginosis pipeline drugs market are intravenous, vaginal, oral, topical, nasal and ophthalmic.
Bacterial Vaginosis Pipeline Drugs Market, by RoA
To get more insights on key RoA, download a free report sample
Major Companies in the Bacterial Vaginosis Pipeline Drugs Market
The major companies in the Bacterial Vaginosis pipeline drugs market are Starpharma Holdings Ltd, AtoGen Co Ltd, BioNTech SE, Evofem Biosciences Inc, Ferring Pharmaceuticals Inc, and Melinta Therapeutics Inc among others.
Bacterial Vaginosis Pipeline Drugs Market, by Companies
For more company insights, download a free report sample
Bacterial Vaginosis Pipeline Drugs Market Overview
Key target | 23S Ribosomal RNA, Bacterial Cell Wall, DNA, Lanosterol 14 Alpha Demethylase, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2.
|
key mechanism of action | 23S Ribosomal RNA inhibitor, Bacterial Cell Wall inhibitor, DNA inhibitor, Lanosterol 14 Alpha Demethylase Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, And Prostaglandin G/H Synthase 2 Inhibitor |
Key molecule types | Small Molecule, Biologic, Peptide, and Recombinant Enzyme
|
Key routes of administration | Intravenous, Vaginal, Oral, Topical, Nasal and Ophthalmic
|
Major companies | Starpharma Holdings Ltd, AtoGen Co Ltd, BioNTech SE, Evofem Biosciences Inc, Ferring Pharmaceuticals Inc, and Melinta Therapeutics Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Bacterial Vaginosis
- The pipeline guide reviews pipeline therapeutics for Bacterial Vaginosis by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bacterial Vaginosis therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bacterial Vaginosis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Bacterial Vaginosis
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Bacterial Vaginosis
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Bacterial Vaginosis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
BioNTech SE
Evofem Biosciences Inc
Ferring Pharmaceuticals Inc
Guangdong Longchuangji Pharmaceutical Co Ltd
Hammock Pharmaceuticals Inc
Hennepin Life Sciences LLC
Melinta Therapeutics Inc
Mucommune LLC
MyBiotics Pharma Ltd
Next Science Ltd
Osel Inc
Pharmiva AB
Profem GmbH
Seed Health Inc
Sichuan Anaerobic Biotechnology Co Ltd
Starpharma Holdings Ltd
Suzhou Kanger Biomedical Co Ltd
Suzhou Ousai Weike Biomedical Technology Co Ltd
TenNor Therapeutics Ltd
Toltec Pharmaceuticals LLC
Zhejiang Xinlifei Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Bacterial Vaginosis drugs market?
In the Bacterial Vaginosis drugs market the key targets are 23S Ribosomal RNA, Bacterial Cell Wall, DNA, Lanosterol 14 Alpha Demethylase, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2.
-
What are the key mechanisms of action in the Bacterial Vaginosis pipeline drugs market?
The key mechanisms of action in the Bacterial Vaginosis pipeline drugs market are 23S Ribosomal RNA inhibitor, Bacterial Cell Wall inhibitor, DNA inhibitor, Lanosterol 14 Alpha Demethylase inhibitor, Prostaglandin G/H Synthase 1 inhibitor, and Prostaglandin G/H Synthase 2 inhibitor.
-
What are the different molecule types in the Bacterial Vaginosis pipeline drugs market?
In the Bacterial Vaginosis pipeline drugs market the different molecule types are small molecule, biologic, peptide, and recombinant enzyme.
-
What are the key routes of administration in the Bacterial Vaginosis pipeline drugs market?
The key routes of administration in the Bacterial Vaginosis pipeline drugs market are intravenous, vaginal, oral, topical, nasal and ophthalmic.
-
What are the major companies in the Bacterial Vaginosis pipeline drugs market?
The leading companies in the Bacterial Vaginosis pipeline drugs market are Starpharma Holdings Ltd, AtoGen Co Ltd, BioNTech SE, Evofem Biosciences Inc, Ferring Pharmaceuticals Inc, and Melinta Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.